MA28302A1 - Derives de sulfonamides pour le traitement de maladies - Google Patents
Derives de sulfonamides pour le traitement de maladiesInfo
- Publication number
- MA28302A1 MA28302A1 MA29201A MA29201A MA28302A1 MA 28302 A1 MA28302 A1 MA 28302A1 MA 29201 A MA29201 A MA 29201A MA 29201 A MA29201 A MA 29201A MA 28302 A1 MA28302 A1 MA 28302A1
- Authority
- MA
- Morocco
- Prior art keywords
- diseases
- treatment
- sulfonamide derivatives
- conditions
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
- C07D217/06—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with the ring nitrogen atom acylated by carboxylic or carbonic acids, or with sulfur or nitrogen analogues thereof, e.g. carbamates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C311/08—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP04290169 | 2004-01-22 | ||
GB0406387A GB0406387D0 (en) | 2004-03-22 | 2004-03-22 | Sulfonamide derivatives for the treatment of diseases |
US60026004P | 2004-08-09 | 2004-08-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
MA28302A1 true MA28302A1 (fr) | 2006-11-01 |
Family
ID=34890770
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA29201A MA28302A1 (fr) | 2004-01-22 | 2006-07-21 | Derives de sulfonamides pour le traitement de maladies |
Country Status (7)
Country | Link |
---|---|
CR (1) | CR9838A (es) |
CY (1) | CY1107107T1 (es) |
EC (1) | ECSP066700A (es) |
HK (1) | HK1096379A1 (es) |
HR (1) | HRP20070542T3 (es) |
IL (1) | IL176564A (es) |
MA (1) | MA28302A1 (es) |
-
2006
- 2006-06-26 IL IL176564A patent/IL176564A/en not_active IP Right Cessation
- 2006-07-13 EC EC2006006700A patent/ECSP066700A/es unknown
- 2006-07-21 MA MA29201A patent/MA28302A1/fr unknown
-
2007
- 2007-03-30 HK HK07103436.9A patent/HK1096379A1/xx not_active IP Right Cessation
- 2007-11-28 HR HR20070542T patent/HRP20070542T3/xx unknown
- 2007-12-20 CY CY20071101628T patent/CY1107107T1/el unknown
-
2008
- 2008-03-27 CR CR9838A patent/CR9838A/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CR9838A (es) | 2008-04-21 |
IL176564A0 (en) | 2006-10-31 |
CY1107107T1 (el) | 2012-10-24 |
ECSP066700A (es) | 2006-10-31 |
HK1096379A1 (en) | 2007-06-01 |
HRP20070542T3 (en) | 2008-02-29 |
IL176564A (en) | 2011-11-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA27840A1 (fr) | Derives de (2-hydroxy-2-(4-hydroxy-3-hydroxymethylphenyl)-ethylamino)-propylphenyle servant d'agonistes beta2 | |
MA27174A1 (fr) | Derives de nicotinamide utiles comme inhibiteurs de pde4. | |
MA27452A1 (fr) | Derives d'indole servant d'agonistes beta-2 | |
MA30289B1 (fr) | Dérivés d'amines | |
MA29170B1 (fr) | Derives puriniques agissant comme des agonistes du recepteur a2a | |
TN2009000112A1 (fr) | Derives de sulfonamides servant d'agonistes adrenergiques et d'antagonistes muscariniques | |
MA32466B1 (fr) | Derives de triazole utiles pour le traitement de maladies | |
MA30911B1 (fr) | Nouveaux derives de sulfonamide en tant qu'antagonistes de bradykinine | |
MA31949B1 (fr) | Dérivés d'aminotriazole comme agonistes d'alx | |
MA27439A1 (fr) | Quinazolinones spirocondensees nouvelles et leur utilisation comme inhibiteurs de phosphodiesterase | |
MA27647A1 (fr) | Antagonistes de ccr5 utiles comme agents therapeutiques | |
MA30696B1 (fr) | Derives de l'acide (3-amino-1,2,3,4-tetrahydro-9h-carbazol-9-yl)-acetique | |
MA29411B1 (fr) | 1h-quinazoline -2,4-diones et leur utilisation en tant que ligands du recepteur ampa | |
MA28747B1 (fr) | Dérivés de pyridine | |
MA27451A1 (fr) | Derives de thiazole pour le traitement de troubles neurodegeneratifs | |
MA27009A1 (fr) | Derives de pyrazole pour le traitement d'une infection par le vih | |
MA27443A1 (fr) | Oxazoles et thiazoles nouveaux servant d'inhibiteurs du facteur de croissance transformant (tgf) | |
MA27190A1 (fr) | Derives de tropane servant de modulateurs de ccr5 | |
MA29213B1 (fr) | Quinolones a substitution macrolones - amino | |
TN2010000230A1 (fr) | Agonistes nouveaux des recepteurs de glucocorticoides | |
MA29926B1 (fr) | Derives de pyrazine | |
SE0302760D0 (sv) | New compounds | |
MA30406B1 (fr) | Nouveaux composes | |
TNSN08137A1 (fr) | Derives de carboxamides servant d'antagonistes des recepteurs muscariniques | |
MA29377B1 (fr) | Derives de la pyrimidine pour traitement de troubles a caractere hyperproliferatif |